Contact
Please use this form to send email to PR contact of this press release:
Forty Seven, Inc. to Present New Clinical and Preclinical Data on Magrolimab and FSI-174 at 61st ASH Annual Meeting
TO:
Please use this form to send email to PR contact of this press release:
Forty Seven, Inc. to Present New Clinical and Preclinical Data on Magrolimab and FSI-174 at 61st ASH Annual Meeting
TO: